An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the trea...

by Krolewiecki, A., Enbiale, W., Gandasegui, J., van Lieshout, L., Kepha, S., Messa Junior, A., Bengtson, M., Gelaye, W., Escola, V., Martinez Valladares, María, Cambra-Pellejà, M., Algorta, J., Martí-Soler, H., Fleitas, P., Ballester, M.R., Doyle, S.R., Williams, N.A., Legarda, A., Mandomando, I., Mwandawiro, C., Muñoz, J.
Published 2022